Top Markets
Coin of the day
AmCad BioMed Corporation AmCad BioMed Corporation

AmCad BioMed Corporation

4188
Rank in Stocks #29617
AmCad BioMed Corporation develops computer-aided detection and diagnosis (CAD)... AmCad BioMed Corporation develops computer-aided detection and diagnosis (CAD) software devices primarily in Taiwan. It offers products for early detection and diagnosis of various diseases. The company's products include AmCAD-UT Detection, a CAD device for ultrasound images of thyroid nodules; and AmCAD-UO for detection of obstructive sleep apnea on awake patients. It also developing AmCAD-US, a software device for visualizing and quantifying statistical distributions of backscattered signals echoed by tissue compositions in the body from FDA-cleared ultrasound systems; and AmCAD-UB, an AI Solution for Breast Lesion Detection. The company was incorporated in 2008 and is based in Taipei City, Taiwan.
Share Price
$0.32117018
Market Cap
$20.34M
Change (1 day)
-0.98%
Change (1 year)
-34.41%
Country
TW
Trade AmCad BioMed Corporation (4188)

Category

EPS for AmCad BioMed Corporation (4188)
EPS as of 2026 TTM: 0
According to AmCad BioMed Corporation latest financial reports and stock price the company's current EPS (TTM) is 0. At the end of 2026 the company had a EPS of 0 equal to its 2026 EPS that were of 0.
EPS history for AmCad BioMed Corporation from 2026 to 2026
EPS at the end of each year
Year EPS Change
Not enough data for the provided dates.
EPS for similar companies or competitors
Company EPS EPS Difference Country
- -
DE
- -
CA
$8.67 -
US
$4.63 -
US
$1.61 -
US